Valuation Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 40.24 USD | +0.85% |
|
-4.05% | -8.65% |
Company Valuation: Scholar Rock Holding Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 872.1 | 467.6 | 1,356 | 4,046 | 4,493 | 4,901 | - | - |
| Change | - | -46.39% | 190.08% | 198.32% | 11.06% | 9.06% | - | - |
| Enterprise Value (EV) 1 | 709.3 | 414 | 1,304 | 3,918 | 4,270 | 4,584 | 4,490 | 4,511 |
| Change | - | -41.63% | 215.07% | 200.38% | 8.97% | 7.37% | -2.05% | 0.46% |
| P/E | -6.92x | -4x | -9.45x | -17.5x | -13.4x | -12.3x | -15.6x | -30.8x |
| PBR | 5.3x | 2.07x | 6.96x | 11x | 20.6x | 18.5x | 16.2x | 17.3x |
| PEG | - | 0.1x | 0.8x | -0.7x | -0.4x | 54.25x | 0.7x | 0.6x |
| Capitalization / Revenue | 46.3x | 14.1x | - | - | - | 863x | 34.5x | 12.4x |
| EV / Revenue | 37.7x | 12.5x | - | - | - | 807x | 31.6x | 11.5x |
| EV / EBITDA | -5.57x | - | - | - | -11.1x | -10.7x | -14.5x | -39.3x |
| EV / EBIT | -5.46x | -3.08x | -7.62x | -15.5x | -11.1x | -10.5x | -13x | -28x |
| EV / FCF | -5.37x | -3.1x | -8.98x | -19.5x | -14.2x | -16.5x | -20.5x | -53.5x |
| FCF Yield | -18.6% | -32.3% | -11.1% | -5.13% | -7.04% | -6.04% | -4.88% | -1.87% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -3.59 | -2.26 | -1.99 | -2.47 | -3.29 | -3.283 | -2.584 | -1.308 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18.82 | 33.19 | - | - | - | 5.677 | 142.2 | 393.7 |
| EBITDA 1 | -127.3 | - | - | - | -383 | -429.2 | -308.8 | -114.9 |
| EBIT 1 | -129.9 | -134.4 | -171.3 | -252.1 | -384.6 | -437.1 | -345.3 | -160.8 |
| Net income 1 | -131.8 | -134.5 | -165.8 | -246.3 | -377.9 | -429.8 | -359.7 | -178.7 |
| Net Debt 1 | -162.8 | -53.53 | -51.84 | -127.7 | -223.8 | -316.5 | -410.4 | -390 |
| Reference price 2 | 24.84 | 9.05 | 18.80 | 43.22 | 44.05 | 40.24 | 40.24 | 40.24 |
| Nbr of stocks (in thousands) | 35,108 | 51,663 | 72,143 | 93,615 | 102,007 | 121,785 | - | - |
| Announcement Date | 3/7/22 | 3/7/23 | 3/19/24 | 2/27/25 | 3/3/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -12.16x | 800.15x | -10.59x | -.--% | 4.86B | |
| 18.77x | 6.69x | 13.41x | 1.58% | 65B | |
| 35.3x | 6.27x | 18.74x | 0.92% | 51.2B | |
| 27.56x | 7.53x | 23.83x | 0.05% | 51.19B | |
| 34.01x | 3.32x | 14.33x | -.--% | 43.93B | |
| 48.9x | 5.59x | 30.73x | -.--% | 41.96B | |
| -18.47x | 189.62x | -19.51x | -.--% | 38.14B | |
| 28.97x | 8.21x | 21.25x | 0.37% | 33.24B | |
| 29.19x | 6.17x | 16.01x | -.--% | 25.2B | |
| 30.74x | 5.69x | 19.09x | -.--% | 22.5B | |
| Average | 22.28x | 103.92x | 12.73x | 0.29% | 37.72B | |
| Weighted average by Cap. | 25.48x | 34.99x | 15.15x | 0.44% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SRRK Stock
- Valuation Scholar Rock Holding Corporation
Select your edition
All financial news and data tailored to specific country editions
